CN1118263A - Life star-Chinese medicine for cancers - Google Patents

Life star-Chinese medicine for cancers Download PDF

Info

Publication number
CN1118263A
CN1118263A CN 94112507 CN94112507A CN1118263A CN 1118263 A CN1118263 A CN 1118263A CN 94112507 CN94112507 CN 94112507 CN 94112507 A CN94112507 A CN 94112507A CN 1118263 A CN1118263 A CN 1118263A
Authority
CN
China
Prior art keywords
gram
herba
medicine
radix
medicinal liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 94112507
Other languages
Chinese (zh)
Inventor
毕盛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 94112507 priority Critical patent/CN1118263A/en
Publication of CN1118263A publication Critical patent/CN1118263A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

"Life Star", a Chinese patent medicine for curing cancers with total effective rate of 89.7% and no any toxic by-effect is prepared with 16 Chinese-medicinal materials such as tricuspid curdania wood, subprostrate sophora root, barbat skullcap, red sage root, oldenlandia, etc. through decoting, immersing in alcohol, concentrating, drying, breaking, granulating and sterilizating.

Description

The star of anticancer Chinese patent medicine-life
The present invention relates to a kind of medicine, particularly Chinese patent medicine.
The Chinese medicine of treatment cancer has many at present, as rolling up disclosed<a kind of compound anticancer capsule preparation on the 41st phase at Gazette of Patent for Invention the 9th〉(application number 9210270.X), the component of this compound capsule is made up of Mylabris, Venenum Bufonis, Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae, Herba Solani Lyrati, Radix Ginseng, the Radix Astragali etc.Technical processs such as preparation method comprises pulverizing, extraction, concentrates, granulation.Its weak point is that the contained cantharidin toxic action of Mylabris is quite big, very easily causes gastroenteritis and gastritis; The bufotoxin that Venenum Bufonis is contained can cause that patient respiratory is urged, muscle spasm, arrhythmia, at last paralysis and dead.Its cure rate and produce effects are very low again, only are 12.6%, and indication again seldom, only limit to two kinds of pulmonary carcinoma and colorectal cancer.
The object of the present invention is to provide a kind of cure rate height, have no side effect, widely applicable anticancer Chinese patent medicine.
Purpose of the present invention can realize by following measure: a kind of star of anticancer Chinese patent medicine-life is characterized in that: its every medicine is prepared from by following material medicine:
Lignum Cudraniae tricuspidatae 2-3.3 Keshan Radix Sophorae Tonkinensis 1.3-2.0 gram
Herba Scutellariae Barbatae 2-2.6 gram Radix Salviae Miltiorrhizae 0.67-1.0 gram
Herba Pileae Scriptae 0.67-1.0 gram Herba Hedyotidis Diffusae 2.0-2.3 gram
Rhizoma Atractylodis Macrocephalae 0.53-0.67 kairine ZHICAO 0.4-0.67 gram
Herba Epimedii 0.8-1.0 Radix Ginseng 0.53-0.67 gram
Radix Astragali 1.3-2.0 gram Fructus Lycii 0.67-0.8
Caulis Spatholobi 1.3-2.0 gram Tremella 0.48-0.5 gram
Herb Gynostemmae Pentaphylli 0.3-0.53 gram Herba Selaginellae Doederleinii 2.0-2.3 gram
The preparation technology of medicine of the present invention is as follows: get 1/2 of Ganoderma lucidum seu Japonicum total amount, it is standby to cross 120 mesh sieves after pulverizing; The crude drug of respectively distinguishing the flavor of of remainder mixed decoct with water three times, be 1-2 hour each heat time heating time, filters respectively and merge medicinal liquid, leaves standstill and treat to get supernatant after its sedimentation, it is concentrated into proportion=1.1-1.3 and weighs; Add medicinal alcohol in above-mentioned concentrated medicament, medicinal liquid and alcoholic acid weight ratio are 1: 2, stir the back standing sedimentation, get supernatant liquid filtering distillation filtrate recycling ethanol; Remaining medicinal liquid concentrates and is paste, carries out drying again with after above-mentioned 120 purpose Ganoderma grass meals mix; 100 mesh sieves are pulverized and crossed to the extractum that drying is good, transfers profit to granulate with medicinal ethanol then and carry out drying again; Carry out cobalt 60 irradiations after the packing.
Crude drug of the present invention is identical with conventional Chinese medicine, is broadly divided into four parts, i.e. " monarch, minister, help, make ".The monarch drug that plays a major role at cancer is Lignum Cudraniae tricuspidatae and Radix Sophorae Tonkinensis.Wherein the main effect of Lignum Cudraniae tricuspidatae is " blood-activating analgetic, a relieving cough and resolving phlegm ", and sarcoma S-180, cervical cancer 17 and ehrlich carcinoma are all had significant inhibitory effect.Radix Sophorae Tonkinensis has " heat-clearing and toxic substances removing, reducing swelling and alleviating pain " effect, and the nucleic acid that its contained effective ingredient can not only anticancer is synthetic, also has the effect of excited reticuloendothelial system.Their consumption: the former is 2.0-3.3 gram/grain, and the latter is 1.3-2.0 gram/grain.The ministerial drug that auxiliary monarch drug is strengthened therapeutical effect to cancer, primary symptom has Herba Scutellariae Barbatae, Radix Salviae Miltiorrhizae, Herba Pileae Scriptae, Herba Hedyotidis Diffusae etc.Wherein Herba Scutellariae Barbatae has the function of " heat-clearing and toxic substances removing, dissipating blood stasis are controlled cancer ", and its consumption is a 2.0-2.6 gram/grain.Radix Salviae Miltiorrhizae has the function of " blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain ", and its consumption is a 0.67-1.0 gram/grain.Herba Pileae Scriptae has the function of " promoting blood circulation and stopping pain, removing dampness and detoxicating ", and its consumption is a 0.67-1.0 gram/grain.Herba Hedyotidis Diffusae has the function of " heat-clearing and toxic substances removing, inducing diuresis to remove edema ", and this medicine can react with the contained alkaloid of Radix Sophorae Tonkinensis and make it to become organic salt simultaneously, and both water soluble was convenient to the absorption of body again, and its consumption is a 2.0-2.3 gram/grain.Assist monarch drug, ministerial drug to strengthen that the assistant of treatment for cancer effect or treatment minor symptom has been helped the Rhizoma Atractylodis Macrocephalae in the adjuvant drug.It has the function of " spleen reinforcing stomach reinforcing, drying dampness to eliminate phlegm ", and its consumption is a 0.53-0.67 gram/grain.The supplementary inhibitory medicine Ganoderma lucidum seu Japonicum that also has the toxicity or the high strong property of medicine to monarch drug, ministerial drug that restrictive function is arranged in the adjuvant drug, it and Herba Hedyotidis Diffusae compatibility have not only been removed the restriction of Radix Sophorae Tonkinensis to " lung has wind and cold or loose stool person to avoid usefulness ", and control the multiplication of cancer curative effect, its consumption is a 0.4-0.67 gram/grain.Also have in the adjuvant drug with the medicine of monarch drug, ministerial drug medicated opposite such as Herba Epimedii as compatibility, it plays the effect of opposing each other and yet also complement each other with the bitter cold of the property of medicine assistant Radix Sophorae Tonkinensis of Gan Wen in order to the lung heat clearing stomach function regulating.Its consumption is a 0.8-1.0 gram/grain.In can guiding side among the present invention there be all medicines to the messenger drug of diseased region: Radix Ginseng, the Radix Astragali, Fructus Lycii, Caulis Spatholobi, Tremella etc.Radix Ginseng, the Radix Astragali are gone into spleen, lung meridian, and Fructus Lycii, Caulis Spatholobi go into liver, kidney channel, and Tremella is gone into the heart, liver, stomach warp.The excited reticuloendothelial system of these medicines energy strengthens its phagocytic function, and can improve the reactivity and the immunity of body.Its consumption is respectively: Radix Ginseng 0.53-0.67 gram/grain, Radix Astragali 1.3-2.0 gram/grain, Fructus Lycii 0.67-0.8 gram/grain, Caulis Spatholobi 1.3-2.0 gram/grain, Tremella 0.43-0.5 gram/grain.In prescription, also have in addition can mediation side in all medicine property of medicine and make body be in medicine such as the Herba Selaginellae Doederleinii and the Herb Gynostemmae Pentaphylli of enhancing nonspecific defense ability kilter.The former is 2.0-2.3 gram/grain its consumption, and the latter is 0.3-0.53 gram/grain.
Preparation technology of the present invention is as follows: relation is got various raw materials according to the above ratio, and wash, pre-treatment such as section.Getting 1/2 of Ganoderma lucidum seu Japonicum full dose, to cross 120 mesh sieves after crushed standby.The crude drug of respectively distinguishing the flavor of of remainder mixed decoct with water three times, be 1-2 hour each heat time heating time.The medicine at every turn fried in shallow oil is filtered, leave standstill after merging medicinal liquid, treat that getting supernatant after its sedimentation is concentrated into proportion-1.1-1.3 with it, and weigh.Add medicinal alcohol to the above-mentioned medicinal liquid that concentrates, the weight ratio of ethanol and medicinal liquid is 2: 1.Leave standstill after the stirring and treat to get supernatant liquid filtering after the sedimentation, ethanol is reclaimed in the filtrate distillation.Concentrate and be paste reclaiming behind the ethanol remaining medicinal liquid, mixes with Ganoderma grass meal below above-mentioned 120 orders again and carry out afterwards drying.Extractum that drying is good is pulverized and is also crossed 100 mesh sieves, and reuse ethanol transfers profit to granulate, and carries out drying then, treats can obtain after the ethanol evaporation graininess semi-finished product of pitchy.Can obtain medicine of the present invention through packing and sterilization again.
The present invention has following advantage compared to existing technology:
1, various cancers are all had curative effect preferably, total effective rate is 89.7%.
2, medicine of the present invention is a pure Chinese medicinal preparation, without any toxic and side effects.
3, patient's taking convenience, the course of treatment is shorter.
4, crude drug is easily got, and cost is lower.
Example 1
Get 2 kilograms of Lignum Cudraniae tricuspidatae, 2 kilograms of Radix Sophorae Tonkinensiss, 2 kilograms of Herba Scutellariae Barbataes, 1 kilogram of Radix Salviae Miltiorrhizae, 0.67 kilogram of Herba Pileae Scriptae, 2.3 kilograms of Herba Hedyotidis Diffusaes, 0.53 kilogram of Rhizoma Atractylodis Macrocephalae, 0.67 kilogram of Ganoderma lucidum seu Japonicum, 1.0 kilograms of Herba Epimedii, 0.53 kilogram of Radix Ginseng, 2 kilograms of Radixs Astragali, 0.67 kilogram of Fructus Lycii, 2 kilograms of Caulis Spatholobis, 0.43 kilogram of Tremella, 2.0 kilograms of Herba Selaginellae Doederleiniis, 0.53 kilogram of Herb Gynostemmae Pentaphylli, wash, pre-treatment such as section.It is standby to get the 0.335 kilogram of back mistake of Ganoderma lucidum seu Japonicum pulverizing 120 mesh sieve.The crude drug of remainder mixed decoct with water three times.With 2 hours,, use 1 hour for the third time for the first time for the second time with 1.5 hours.The medicine of at every turn frying in shallow oil is filtered, merges medicinal liquid, leave standstill sedimentation after 12 hours.Getting supernatant is concentrated into proportion=1.1 with it and weighs.Add 95% medicinal alcohol to the above-mentioned medicinal liquid that concentrates, its weight ratio with medicinal liquid is 2: 1, leaves standstill sedimentation in 12 hours after the stirring, gets its supernatant liquid filtering, with filtrate distillation recovery ethanol.With the concentrated paste that is of medicinal liquid remaining behind the recovery ethanol, carry out drying again with after Ganoderma grass meal below top 0.33 kilogram of 120 order mixes, 100 mesh sieves are pulverized and crossed to the extractum that drying is good, reuse 90% medical ethanol transfers profit to granulate, and then carry out drying, treat after the ethanol evaporation granule of pitchy is incapsulated, and carry out cobalt 60 radiation sterilizations, just can obtain 1000 medicines of the present invention at last.
Example 2
Get 3.3 kilograms of Lignum Cudraniae tricuspidatae, 1.3 kilograms of Radix Sophorae Tonkinensiss, 2.6 kilograms of Herba Scutellariae Barbataes, 0.67 kilogram of Radix Salviae Miltiorrhizae, 1 kilogram of Herba Pileae Scriptae, 2 kilograms of Herba Hedyotidis Diffusaes, 0.67 kilogram of Rhizoma Atractylodis Macrocephalae, 0.4 kilogram of Ganoderma lucidum seu Japonicum, 0.8 kilogram of Herba Epimedii, 0.67 kilogram of Radix Ginseng, 1.3 kilograms of Radixs Astragali, 0.8 kilogram of Fructus Lycii, 1.3 kilograms of Caulis Spatholobis, 0.5 kilogram of Tremella, 2.3 kilograms of Herba Selaginellae Doederleiniis, 0.3 kilogram of Herb Gynostemmae Pentaphylli.Repeat the operation of example 1.Wherein doing with Ganoderma lucidum seu Japonicum is 0.2 kilogram, and the proportion of concentrated solution is 1.3, and the time of leaving standstill is 16 hours.
The using method of medicine of the present invention: 5/time, 3 times/day, oral.
Medicine of the present invention is as follows with similar cancer therapy drug Comparison of therapeutic result:
Figure A9411250700081

Claims (2)

1, a kind of anticancer Chinese patent medicine---the star of life is characterized in that: its every medicine is prepared from by following crude drug:
Lignum Cudraniae tricuspidatae 2~3.3 Keshan Radix Sophorae Tonkinensis 1.3~2.0 grams
Herba Scutellariae Barbatae 2~2.6 gram Radix Salviae Miltiorrhizaes 0.61~1.0 gram
Herba Pileae Scriptae 0.67~1.0 gram Herba Hedyotidis Diffusae 2.0~2.3 grams
The Rhizoma Atractylodis Macrocephalae 0.53~0.67 kairine ZHICAO 0.4~0.67 gram
Herba Epimedii 0.8~1.0 gram Radix Ginseng 0.53~0.67 gram
The Radix Astragali 1.3~2.0 gram Fructus Lycii 0.67~0.8 gram
Caulis Spatholobi 1.3~2.0 gram Tremella 0.43~0.5 gram
Strand lotus 0.3~0.53 gram Herba Selaginellae Doederleinii 2.0~2.3 grams
2, anticancer Chinese patent medicine according to claim 1---the star of life is characterized in that: its preparation technology is as follows: the back mistake of 1/2 pulverizing 120 mesh sieves of getting the Ganoderma lucidum seu Japonicum total amount are standby; The crude drug of respectively distinguishing the flavor of of remainder mixed add the water steaming and decocting three times, be 1-2 hour each heat time heating time, filters respectively and merge medicinal liquid, leaves standstill and treat to get supernatant after its sedimentation, it is concentrated into proportion=1.1-1.3, and weighs; Add medicinal alcohol in above-mentioned concentrated medicament, medicinal liquid and alcoholic acid weight ratio are 1: 2, stir the back standing sedimentation, get supernatant liquid filtering distillation filtrate recycling ethanol; Remaining medicinal liquid concentrates and is paste, carries out drying again with after above-mentioned 120 purpose Ganoderma grass meals mix; 100 mesh sieves are pulverized and crossed to the extractum that drying is good, and row is dry again to transfer the profit granulation with medicinal ethanol then; Carry out cobalt 60 irradiations after the packing.
CN 94112507 1994-09-06 1994-09-06 Life star-Chinese medicine for cancers Pending CN1118263A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 94112507 CN1118263A (en) 1994-09-06 1994-09-06 Life star-Chinese medicine for cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 94112507 CN1118263A (en) 1994-09-06 1994-09-06 Life star-Chinese medicine for cancers

Publications (1)

Publication Number Publication Date
CN1118263A true CN1118263A (en) 1996-03-13

Family

ID=5036185

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 94112507 Pending CN1118263A (en) 1994-09-06 1994-09-06 Life star-Chinese medicine for cancers

Country Status (1)

Country Link
CN (1) CN1118263A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1092969C (en) * 2000-04-11 2002-10-23 杜仰恩 Anticancer Chinese medicine
CN1754550B (en) * 2004-09-30 2010-05-12 广东粤微食用菌技术有限公司 Compound traditional Chinese medicine glossy ganoderma formulation and preparation method
US20130101616A1 (en) * 2003-09-08 2013-04-25 James Dao Compositions of botanical extracts for cancer therapy
CN105126030A (en) * 2015-09-25 2015-12-09 广西中医药大学 Zhuang medicine composition assisted in resisting lung cancer

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1092969C (en) * 2000-04-11 2002-10-23 杜仰恩 Anticancer Chinese medicine
US20130101616A1 (en) * 2003-09-08 2013-04-25 James Dao Compositions of botanical extracts for cancer therapy
CN1754550B (en) * 2004-09-30 2010-05-12 广东粤微食用菌技术有限公司 Compound traditional Chinese medicine glossy ganoderma formulation and preparation method
CN105126030A (en) * 2015-09-25 2015-12-09 广西中医药大学 Zhuang medicine composition assisted in resisting lung cancer
CN105126030B (en) * 2015-09-25 2019-02-05 广西中医药大学 A kind of strong drug composition assisting anti-lung cancer

Similar Documents

Publication Publication Date Title
CN1044974C (en) Anti- hepatitis B preparation
CN1145240A (en) Medicinal compsn. for prevention of Aids virus and cancer
CN1118263A (en) Life star-Chinese medicine for cancers
CN1053189A (en) The preparation method of " promoting blood circulation and restoring paralysis pills "
CN1059556C (en) Compound bufonin of bufo gargarizans
CN1077896A (en) Medicine for psoriasis and manufacture method
CN1242775C (en) Bushenshansong drink and preparation method thereof
CN1044090C (en) Medicine for treating urethral concretion and process for preparing same
CN1134294A (en) Instant granule preparation for strengthening the body resistance to brain tumor
CN1058165C (en) Chinese drugs for curing hepatitis B
CN1180821C (en) Medicine for treating cerebral thrombus and its prepn
CN1175873C (en) Preparation technology of
CN1113804A (en) Antianemic powder and its preparing method
CN100475248C (en) A medicine for treating metrorrhagia and preparation process thereof
CN1589839A (en) Stasis transforming pain relieving particle agent and its preparation method
CN1163252C (en) Tianjian capsule and its preparing process
CN1062168C (en) Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer
CN1098294A (en) Manganning medicine
CN1063074C (en) Chinese herbs injection for treating oncoma (cancer) and preparation method
CN101810683B (en) Chinese medicinal compound preparation for curing migraine and preparation process thereof
CN85106091A (en) Produce the method for anti-embolism regenerative pill
CN1108943A (en) Medicine "Yigankang" for hepatitis B and its preparation
CN101574426A (en) Chinese patent medicament for treating liver diseases and method for preparing same
CN1159926A (en) Instant particles for activating blood circulation and eliminating stasis
CN1899546A (en) Medicinal composition for treating hepatitis B

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication